Today we announced Fund VI, which represents hard work from many members of our team. So grateful to our investors for their support. Read more in @FierceBiotech: @https://www.fiercebiotech.com/biotech/foresite-raises-900m-make-big-bets-one-best-biotech-investment-environments
Today we welcome @xaira_therapeutics to our portfolio, emerging from stealth with $1B in committed capital; jointly incubated by Arch Venture Partners / @rtnarch and @ForesiteLabs and led by Marc Tessier-Lavigne. Read more: endpts.com/in-biggest-ever-b…
We welcome Hadi Tabbaa, our new managing director of investor relations and business development! With 2+ decades of experience, Hadi is set to strengthen our investor partnerships and bring invaluable expertise to Foresite Capital. Welcome aboard, Hadi!
businesswire.com/news/home/2…
Welcoming @cgoncology to our portfolio! We're excited to work with Arthur Kuan and team to address the significant unmet need in bladder cancer. They are laser focused on delivering new treatment options for this difficult to treat patient population. Read more in @FierceBiotech.
CG Oncology has raised the rarely seen crossover round. The pre-IPO rounds have dried up in the biotech bear market—but CG’s fully enrolled phase 3 bladder cancer clinical trial has persuaded investors to put down $105 million.
fiercebiotech.com/biotech/cg…
Scholarship applications for Cohort 14 of #VCUniversity are now open! Created by @VCForward, the scholarship covers tuition, office hours and a curated mentorship component that we’re proud to be a part of. Apply for the life sciences track by 6/23: bit.ly/3NjNXMY
Proud to share the news that XinThera was acquired by @GileadSciences today. We were the founding investor, seeing the potential in their approach to cancer and inflammatory diseases through drugs that block the proteins PARP1 or MK2. endpts.com/gilead-acquires-p…
1
5
643
Aspiring VCs from underrepresented backgrounds: @VCForward is offering full scholarships to Cohort 13 (June 2023) of #VCUniversity, including course tuition, office hours, and dedicated mentorship. Learn more + apply by Friday, 3/24: venturecapitaluniversity.com…
Introducing our blog series featuring chats with our team members. Check out the conversation with Managing Director Michael Rome on the state of healthcare & his expert take on shaping trends & challenges. medium.com/foresite-capital/…
453
Meet the Cohort 12 scholarship recipients!
Replying to @VCForward
Big thanks to our C12 sponsors @ForesiteCapital, @JNJInnovation, Longitude Capital, Omega Funds, @SalesforceVC, @GVteam, and Sofinnova Investments. Your support and leadership are helping us create a stronger, more diverse future for VC. 💪https://teapawt.net/t.co/mLDgVdQ0V3
581
New podcast with the head of medical affairs at our portfolio company @MirvieDx on the state of maternal care and what is needed for meaningful change. The team at Mirvie has set out to identify risks months before symptoms occur.
Alison Cowan, M.D. helps us understand how the breakthrough Mirvie #RNA Platform can create meaningful improvements to the existing model for #PregnancyHealth care in her recent interview with @FierceHealth Podnosis. Listen to learn more: fiercehealthcare.com/provide…
2
Understanding who is at risk for pregnancy complications is the first step toward personalized preventive care. We are proud of the work being done to address this by our portfolio company @MirvieDx. Read Alison Cowan, M.D.’s interview with CNBC to learn more.
What do #PregnancyHealth experts say needs to change to reduce pregnancy-related death? Read Alison Cowan, M.D.’s perspective on the opportunities for prevention and the importance of patient education and empowerment in @CNBC: cnbc.com/2022/10/03/cdc-over…
We're excited to support @folxhealth as they scale their health and wellness platform designed uniquely for the LGBTQIA+ community. Thank you to @amendeznews and @techcrunch for this coverage.
FOLX powers LGBTQ+ telehealth support groups with $30M round tcrn.ch/3epKeyN by @amendeznews
1
Foresite Capital retweeted
What do #PregnancyHealth experts say needs to change to reduce pregnancy-related death? Read Alison Cowan, M.D.’s perspective on the opportunities for prevention and the importance of patient education and empowerment in @CNBC: cnbc.com/2022/10/03/cdc-over…
We're excited to be working with this precision oncology team to bring better, more targeted therapies to people with hard-to-treat cancers.
Today we officially launched Nested Therapeutics – a #biotech company pioneering a next-generation #PrecisionMedicine platform to address hard-to-treat cancers with potential to reach and improve outcomes for millions of patients.👉nestedtx.com👉https://teapawt.net/t.co/MD01ZMe1t5
3
Cohort 11 looks solid! These individuals in the life sciences track will be shaping the future of our industry, and we couldn't be more proud to support this program with our friends at @VCForward.
Introducing #VCUniversity ONLINE’s Cohort 11 Scholarship Recipients!
Get to know these future leaders of the industry:
ventureforward.org/meet-the-…
Apply by June 24th for a full scholarship to #VCUniversity and the new life science track for aspiring life science investors from underrepresented backgrounds.
Cohort 11 of #VCUniversity starts September 1, 2022, and the scholarship application opens today!
Aspiring #VC investor from an underrepresented background? Learn more + apply for a scholarship by Friday, June 24:
venturecapitaluniversity.com…
3
This is a really impressive cohort, and we're so proud of our work with @VCForward and our fellow supporting sponsors. It's small steps like these that will help bring about a more diverse and inclusive future for our industry.
Replying to @VCForward
Thanks to @ForesiteCapital, @JNJInnovation, Longitude Capital, Omega Funds, @SalesforceVC, @ssfllp & Sofinnova Investments for making this program possible. Your support and leadership are helping us create a stronger, more diverse future for venture capital.
Our managing director Michael Rome shares his thoughts on the @Affinivax acquisition by @GSK in our latest blog post: foresitecapital.com/blog/tho…
Congratulations to Foresite Capital Fellow @xinhong_chen for his publication in @NeuroCellPress on non-invasive gene delivery. We're so proud of his accomplishments!
cell.com/neuron/fulltext/S08…
6
Congratulations to our portfolio company @Affinivax on their acquisition by @GSK! A great move to advance their vaccines that combat novel and resistant infectious diseases that currently have no effective immunization strategies.
wsj.com/articles/gsk-bolster…
1









